FDA Inspection 1055638 — Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited — FEI 3007501748

The FDA completed an inspection of Alembic Pharmaceuticals Limited on May 18, 2018 in Vadodara. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 18, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Vadodara (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.